Cited by 12Cancer Genomics and DiagnosticsSarcoma Diagnosis and TreatmentExtracellular vesicles in disease

Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients

Open access
Bodlak, Avery, Chang, Kyle, Channel, Jessica, Treece, Amy L., Donaldson, Nathan, Cost, Carrye R., Garrington, Timothy P., Greffe, Brian +4 more·2021·The Journal of Molecular Diagnostics

Abstract

The detection of tumor-specific nucleic acids from blood increasingly is being used as a method of liquid biopsy and minimal residual disease detection. However, achieving high sensitivity and high specificity remains a challenge. Here, we perform a direct comparison of two droplet digital PCR (ddPCR)-based detection methods, circulating plasma tumor RNA and circulating plasma tumor DNA (ptDNA), in blood samples from newly diagnosed Ewing sarcoma patients. First, we developed three specific ddPCR-based assays to detect EWS-FLI1 or EWS-ERG fusion transcripts, which naturally showed superior sensitivity to DNA detection on in vitro control samples. Next, we identified the patient-specific EWS-FLI1 or EWS-ERG breakpoint from five patient tumor samples and designed ddPCR-based, patient-specific ptDNA assays for each patient. These patient-specific assays show that although plasma tumor RNA can be detected in select newly diagnosed patients, positive results are low and statistically unreliable compared with ptDNA assays, which reproducibly detect robust positive results across most patients. Furthermore, the unique disease biology of Ewing sarcoma enabled us to show that most cell-free RNA is not tumor-derived, although cell-free-DNA burden is affected strongly by tumor-derived DNA burden. Here, we conclude that, even with optimized highly sensitive and specific assays, tumor DNA detection is superior to RNA detection in Ewing sarcoma patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jmoldx.2021.04.003

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 46 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Bodlak, A., Chang, K., Channel, J., Treece, A. L., Donaldson, N., Cost, C. R., Garrington, T. P., Greffe, B., Luna-Fineman, S., Sopfe, J., Loeb, D. M., & Hayashi, M.
Affiliations
  • University of Colorado Denver (US)
  • University of Houston (US)
  • Albert Einstein College of Medicine (US)
  • University of Colorado Anschutz (US)
Corresponding author
Hayashi, Masanori
Venue
The Journal of Molecular Diagnostics
Publisher
Elsevier BV
Published
2021-07
Volume
23
Issue
7
Pages
872-881
ISSN
1525-1578 (ISSN-L)
OpenAlex
W3154075702
Cited by
12
References
46
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Journal of Molecular Diagnostics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Colorado
  • National Institutes of Health (K12HD068372)
  • Saint Baldricks Foundation
  • Hyundai Hope On Wheels
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
Ewing sarcoma, circulating tumor DNA, circulating tumor RNA, liquid biopsy, droplet digital PCR, EWS-FLI1 fusion, minimal residual disease, cell-free RNA, cell-free DNA, sensitivity and specificity
MeSH terms
Circulating Tumor DNA, Adolescent, Child, Female, Humans, Male, RNA, Neoplasm, Sarcoma, Ewing, Transcription Factors, Translocation, Genetic, Biomarkers, Tumor, Reproducibility of Results, Oncogene Proteins, Fusion, Polymerase Chain Reaction, RNA-Binding Protein EWS, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review